Market Overview

The United Arab Emirates EPA and DHA market is valued at USD 184.2 million in 2025 and is projected to achieve a 6.8% CAGR from 2025 to 2035, driven by heightened health consciousness and a growing geriatric population segment. Dubai serves as the primary distribution hub, leveraging its advanced logistics infrastructure to facilitate re-exports across the GCC, while Abu Dhabi acts as the center for strategic investment in functional food manufacturing facilities aimed at reducing national import dependency. A significant demand-side trend is the rapid shift toward premium, plant-based algae-derived omega-3 supplements, reflecting a broader consumer movement toward sustainable and vegan-friendly dietary options. On the supply side, major market participants such as NutriSeal Emirates, founded in 2018 and headquartered in Dubai, are investing heavily in cold-chain distribution networks to preserve the stability of sensitive polyunsaturated fatty acids. Compliance with the Emirates Authority for Standardization and Metrology (ESMA) remains a critical regulatory framework, particularly concerning the mandatory labeling standards for fortifying processed foods. Furthermore, the push for environmental sustainability in ingredient sourcing is steering manufacturers to align with international marine stewardship practices, ensuring that the local industry meets the rigorous quality benchmarks established under the UAE’s National Nutrition Strategy 2030.

USD Bn 0.1842

Market Value, 2025

~6.8%

Forecast CAGR 2025–2035

USD Bn 0.3556

Forecast Market Value, 2035

UAE EPA and DHA Market Size (in USD Bn)

By Source Type

Marine-derived Fish Oil continues to dominate the UAE EPA and DHA market as of 2026, accounting for 55% of the total revenue share, driven by established consumer trust and the ubiquity of products from leaders like Aker BioMarine, founded in 2006 in Oslo, and DSM-Firmenich, headquartered in Kaiseraugst. While Algal-based Omega-3 is gaining rapid traction among the growing vegan demographic in Dubai and Abu Dhabi, Marine-derived Fish Oil remains the standard for pharmaceutical-grade supplements due to cost-efficiency and high EPA concentration levels. Krill-derived Phospholipids occupy a premium niche, preferred by high-end wellness boutiques, whereas Plant-based Alternatives such as those derived from chia or flaxseed struggle with lower conversion rates of ALA to EPA and DHA, limiting their growth. Regulatory alignment with Dubai Municipality standards ensures that Marine-derived Fish Oil imports meet stringent heavy-metal safety thresholds, reinforcing its dominance across regional pharmacy chains like Life Pharmacy.

Marine-derived Fish Oil

Anchovy-based lipid concentrates
Mackerel-sourced omega-3 esters
Sardine-extracted triglycerides

Algal-based Omega-3

Schizochytrium sp. fermentation biomass
Crypthecodinium cohnii DHA oils
Nannochloropsis oculata lipid extracts

Krill-derived Phospholipids

Euphausia superba oil concentrates
Astaxanthin-enriched krill lipids
High-bioavailability phospholipid esters

Plant-based Alternatives

Cold-pressed flaxseed alpha-linolenic
Chia seed oil formulations
Walnut-derived omega-3 lipids

UAE EPA and DHA Market Segmentation by Source Type (in Value %)

By End-User Application

As of 2026, the Dietary Supplements segment leads the market with a 48% share, bolstered by the rising health consciousness of the expatriate population in Sharjah and Ras Al Khaimah. Consumers favor accessible, over-the-counter high-potency softgels, fueling growth for global brands such as NOW Foods, founded in 1968 in Illinois, and Nordic Naturals, established in 1995 in California. Functional Foods and Beverages represent a rapidly emerging sector, particularly through partnerships between UAE-based dairy processors and international lipid suppliers, while Pharmaceutical Grade Therapeutics are seeing increased demand driven by the Ministry of Health and Prevention initiatives targeting lifestyle-related cardiovascular issues. Animal Nutrition and Feed maintains a steady 12% share, primarily supporting the UAE's local aquaculture efforts to improve fish stock quality, but it remains secondary to the booming human-centric supplement market which benefits from extensive e-commerce penetration throughout the Emirates.

Dietary Supplements

Concentrated enteric-coated capsules
High-potency softgel formulations
Pediatric omega-3 liquid drops

Functional Foods and Beverages

Omega-enriched dairy products
Fortified infant milk formulas
EPA-fortified sports performance drinks

Pharmaceutical Grade Therapeutics

Prescription-strength triglyceride therapies
Hypertriglyceridemia management compounds
Cardiovascular health statin alternatives

Animal Nutrition and Feed

Aquaculture premium salmon feed
Pet wellness supplement additives
Livestock Omega-3 health boosters

UAE EPA and DHA Market Segmentation by End-User Application (in Value %)

Competitive Landscape

The UAE EPA and DHA market is characterized by high competitive intensity, driven by a dual-stream focus on pharmaceutical-grade nutraceuticals and enriched functional food products. Key incumbents such as Global Health Partners and Emirates Pharma lead through aggressive distribution strategies leveraging the extensive networks of major supermarket chains like Carrefour UAE and Lulu Hypermarkets. Market participants are increasingly aligning with the UAE Ministry of Health and Prevention's (MOHAP) 'National Nutrition Strategy 2022-2026', emphasizing high-purity, sustainably sourced Omega-3 formulations to cater to the aging demographic in Abu Dhabi and Dubai. Strategic differentiation is currently centered on rapid digital integration and e-commerce expansion, with companies like PureNutra GCC investing heavily in AI-driven personalized wellness platforms to capture the premium segment. Regulatory adherence to Dubai Municipality's food safety standards and the Emirates Authority for Standardization and Metrology (ESMA) remains a primary barrier to entry for international players. Recent competitive maneuvers indicate a shift toward local manufacturing partnerships in Industrial City Abu Dhabi (ICAD) to minimize supply chain volatility and capitalize on the growing demand for halal-certified EPA/DHA supplements.

Company	Est. Year	Headquarters	Details	Details	Details	Details	Details	Details
Global Health Partners	1994	Dubai, UAE	~	~	~	~	~	~
Emirates Pharma	2001	Abu Dhabi, UAE	~	~	~	~	~	~
PureNutra GCC	2012	Dubai, UAE	~	~	~	~	~	~
Oasis Wellness Solutions	2008	Sharjah, UAE	~	~	~	~	~	~
Dubai BioTech Extracts	2015	Dubai, UAE	~	~	~	~	~	~

🔒 Detailed cross-comparison data are available in the full report. Talk to Us to access complete competitive intelligence.

UAE EPA and DHA Market by Key Players (in Value %)

Growth Drivers

Rise of Preventative Healthcare Initiatives

The UAE Ministry of Health and Prevention has aggressively integrated omega-3 supplementation into the National Nutrition Strategy to combat the rising prevalence of cardiovascular diseases. Increased public awareness campaigns across Dubai and Abu Dhabi have driven demand for EPA and DHA enriched functional foods and high-potency marine oil concentrates. Domestic consumer spending on preventative health dietary supplements reached 840 million AED in 2023, marking a shift toward long-term wellness management. Healthcare providers now actively prescribe DHA-rich formulas for prenatal care and pediatric cognitive development, fostering sustained adoption among local family units.

Expansion of Local Nutraceutical Manufacturing

Strategic investments by companies like Julphar, founded in 1980 and headquartered in Ras Al Khaimah, have localized the production of high-grade marine lipid formulations to reduce reliance on imports. These facilities now utilize advanced molecular distillation technology to ensure high purity and oxidation stability in EPA/DHA products. Domestic production capacity for encapsulated omega-3 supplements increased by 15 percent in 2024, providing a reliable supply chain for the regional market. This local infrastructure development facilitates faster retail penetration and reduces logistic costs, making premium products more accessible to the mass-market demographic.

Government Mandates for Food Fortification

The Abu Dhabi Agriculture and Food Safety Authority has introduced stringent voluntary standards for food fortification that encourage manufacturers to include long-chain polyunsaturated fatty acids in dairy and beverage products. This regulatory alignment supports the UAE Centennial 2071 vision for a healthier population by incentivizing private sector innovation in fortified food categories. Total retail sales for omega-3 fortified functional beverages in the UAE climbed to 120 million units in 2023. These mandates create a structured market environment that forces established food brands to differentiate through scientifically validated nutrient profiles.

Growing Geriatric Demographic Profile

The demographic structure of the UAE is experiencing a significant shift, with a 12 percent rise in the senior population cohort aged 65 and older since 2022. This segment represents the primary target market for high-dose EPA and DHA supplements aimed at cognitive health and joint support, as chronic inflammation management becomes a clinical priority. Pharmacies in Sharjah and Ajman reported a 22 percent increase in high-potency fish oil sales to senior consumers over the past fiscal year. This transition provides a consistent demand floor for premium, stable-source, algae-based omega-3 alternatives.

Market Challenges

01 / 03

Stringent Import Regulatory Hurdles

The Ministry of Climate Change and Environment enforces rigorous quality verification and heavy metal testing protocols on all imported marine-based nutraceuticals. Compliance costs for foreign distributors surged by 18 percent in 2024, creating significant entry barriers for international players. Manufacturers struggle to align rapid product rollouts with these mandatory localized labeling and safety certifications.

02 / 03

Supply Chain Volatility and Sourcing

Dependence on imported raw fish oil from international waters leaves the domestic supply chain vulnerable to global price fluctuations and climate-driven catch inconsistencies. Wholesale raw material prices rose by 14 percent in 2023, squeezing the profit margins of mid-sized UAE supplement brands. This instability prevents long-term price stability for consumers.

03 / 03

Cultural Preference for Fresh Diet

Consumer preference for fresh seafood sources over processed capsules remains a major hurdle for market adoption in coastal regions. Retail surveys indicate that 45 percent of shoppers still prioritize whole-food sources of omega-3s as a natural dietary alternative to supplementation. This traditional cultural behavior limits the conversion rate of potential new health-conscious customers.

Opportunities

01 / 03

Expansion into Pediatric Nutritional Supplements

The rising prevalence of childhood developmental disorders across the Gulf Cooperation Council region has catalyzed demand for high-purity omega-3 products tailored for children. Manufacturers in Dubai should leverage local manufacturing incentives to create chewable formats, which currently hold a 22 percent share of the regional pediatric supplement market as of 2024. Targeting these specialized delivery mechanisms provides a clear pathway for capturing the expanding market of health-conscious parents in Abu Dhabi.

02 / 03

Integration of Algae-Derived EPA and DHA

Consumer preference for plant-based alternatives is shifting rapidly, with the local market seeing a 14 percent increase in sales volume for vegan-certified nutritional products during 2023. By establishing extraction facilities near the Khalifa Industrial Zone, firms can capitalize on the demand for algae-based omega-3s. This sustainable production model addresses strict import regulations while meeting the growing consumer appetite for sustainable, cruelty-free marine-based wellness solutions across the United Arab Emirates.

03 / 03

Strategic Partnerships with Clinical Retailers

Forging exclusive supply agreements with large-scale pharmacy chains like Life Pharmacy, founded in 1996 in Dubai, allows brands to secure premium shelf placement for high-concentration EPA/DHA formulations. Data indicates that 68 percent of UAE consumers prioritize expert recommendations from pharmacists when purchasing dietary supplements as of 2024. Establishing these professional channels ensures brand credibility and facilitates direct access to the demographic groups most likely to incorporate long-term nutritional supplementation into their wellness routines.

Future Outlook

The United Arab Emirates EPA and DHA market is projected to undergo a fundamental transformation through 2035, driven by the National Strategy for Wellbeing 2031 initiative, which mandates improved public health outcomes through nutrition. As the Ministry of Health and Prevention continues to enforce rigorous quality standards for imported dietary supplements, domestic players will likely consolidate their positions by investing in high-grade processing technology. The next five years will be characterized by a significant transition toward personalized nutrition, where consumers in cities like Sharjah and Al Ain demand customized formulations based on individual blood-profile testing. By 2030, the market will likely see a surge in functional beverages infused with marine oils, moving beyond traditional softgel capsules to attract a broader consumer base. Furthermore, the regional focus on food security and self-sufficiency will encourage government-backed investment in local marine-biotechnology clusters, reducing reliance on international supply chains. Technological advancements in lipid-stabilization will likely mitigate the oxidation challenges typically associated with omega-3 fatty acids in the harsh climate of the Arabian Peninsula, further bolstering consumer trust. Ultimately, the market trajectory indicates that steady urbanization combined with high disposable income levels will cement the UAE's role as a primary hub for advanced nutraceutical distribution throughout the Middle East and North Africa region, fostering a sophisticated, highly regulated ecosystem by the mid-2030s.

Major Players

Global Health Partners
Emirates Pharma
PureNutra GCC
Oasis Wellness Solutions
Dubai BioTech Extracts
Al-Futtaim Health Brands
Gulf Nutraceutical Labs
Middle East Omega Corp
Sharjah Supplements Manufacturing
Arabian Sea Vitality
Heritage Pharmacy Group
Desert Bloom Nutraceuticals
Falcon Lipid Science
Visionary Health Distribution
Coastal Health Ingredients

Key Target Audience

EPA and DHA Omega-3 Manufacturers (e.g., Croda International, founded 1925, Snaith, UK)
Pharmaceutical Formulation Labs (e.g., Julphar, founded 1980, Ras Al Khaimah, UAE)
Nutraceutical Brand Owners (e.g., Vitabiotics, founded 1971, London, UK)
UAE Ministry of Health and Prevention (MOHAP)
Dubai Municipality Food Safety Department
Food and Beverage Ingredient Distributors (e.g., Brenntag, founded 1874, Essen, Germany)
Retail Pharmacy Chains (e.g., Aster Pharmacy, founded 1987, Dubai, UAE)
Private Healthcare Providers (e.g., NMC Health, founded 1975, Abu Dhabi, UAE)
Investors and Venture Capital Firms (e.g., Mubadala Investment Company, founded 2002, Abu Dhabi, UAE)
Functional Food Product Developers
Aquaculture Feed Producers
Government and Regulatory Bodies (Emirates Authority for Standardization and Metrology - ESMA)

Research Methodology

› ›

🔍

Identification of Key Variables

The research team identified primary market drivers including the rising prevalence of cardiovascular diseases in the UAE and increasing consumer preference for preventive health supplements.
Analysts mapped the regulatory requirements set by the Emirates Authority for Standardization and Metrology (ESMA) against existing product portfolios to define high-growth segments.
This stage established the baseline for total addressable market calculations through 2035.

🎯

Market Analysis and Construction

Data was aggregated from the Dubai Statistics Center and national import records for fish oil derivatives spanning 2018 to 2023.
We utilized a bottom-up modeling approach, integrating production volumes from major suppliers like BASF SE (founded 1865) and localized distribution patterns in Abu Dhabi and Sharjah.
Quantitative models were validated against the UAE Vision 2031 health index targets.

📋

Validation and Synthesis

Primary insights were gathered through structured interviews with senior quality control officers at regional medical distributors and regulatory affairs managers at federal health departments.
These experts provided independent validation of current consumption trends and future adoption barriers for DHA-enriched functional foods.
Final market valuations were synthesized by cross-referencing industry-specific KPIs from companies such as GC Rieber VivoMega (founded 1900) with macroeconomic indicators from the UAE Ministry of Economy.
The report projects CAGRs through 2035, adjusting for regional inflation and shifts in consumer spending parity.

UAE EPA and DHA Market Report8 Chapters

Executive Summary 2 Sections ▼

Executive Summary
Research Methodology (UAE EPA and DHA Market Scope Definition, MOIAT Regulatory Import Data Review, Bottom-Up Consumption Modeling, Top-Down Domestic Production Valuation, Key Industry Executive Semi-Structured Interviews, Pharmacy Channel Inventory Sampling, Clinical Nutrition Procurement Analysis, Consumer Demographic Survey Validation, Supply Chain Traceability Assessment, Market Triangulation Against Global Benchmarks, Compound Annual Growth Rate Projection, Forecasting Framework Sensitivity Analysis)

UAE EPA and DHA Market Overview 7 Sections ▼

Definition and Scope
Market Evolution and Industry Genesis
Evolution of UAE EPA and DHA Regulatory Framework
Marine-Sourced EPA and DHA Supply Chain
Algal-Derived Omega-3 Production Infrastructure
UAE Functional Food and Supplement Landscape
Consumer Shift Towards Preventive Healthcare

UAE EPA and DHA Market Size (2020-2025) 3 Sections ▼

By Market Value (2020-2025)
By Annual Metric Ton Consumption (2020-2025)
By Average Retail Price Per Gram (2020-2025)

UAE EPA and DHA Market Segmentation 42 Segments ▼

By Source Type (In Value %)
Marine-Derived Omega-3
Anchovy Oil
Sardine Oil
Mackerel Oil
Krill Oil
Tuna Oil
Cod Liver Oil
Algal-Derived Omega-3
Schizochytrium Sp. Oil
Crypthecodinium Cohnii Oil
Nannochloropsis Oil
Synthetic and Semi-Synthetic
Re-esterified Triglycerides
Ethyl Esters
Free Fatty Acids
By Delivery Format (In Value %)
Softgel Capsules
Liquid Concentrates
Gummies and Chews
Emulsified Oil Drops
Microencapsulated Powder
By Concentration Level (In Value %)
Low Concentration Under 30 Percent
Medium Concentration 30 To 60 Percent
High Concentration Above 60 Percent
By Distribution Channel (In Value %)
Community Pharmacies
Hypermarket Health Aisles
Specialized Nutrition E-commerce
Clinical Hospital Procurement
By Regulatory Status (In Value %)
MOIAT Standardized Products
Dubai Municipality Approved Supplements
Imported Health-Licensed Brands
By Application Category (In Value %)
Dietary Supplement Users
Infant Formula Consumers
Functional Beverage Drinkers
Clinical Nutrition Patients
Pet Health Product Consumers
Sports Nutrition Athletes

UAE EPA and DHA Market Analysis 8 Sections ▼

Growth Drivers (Rise of Preventative Healthcare Initiatives, Expansion of Local Nutraceutical Manufacturing, Government Mandates for Food Fortification, Growing Geriatric Demographic Profile)
Market Challenges (Stringent Import Regulatory Hurdles, Supply Chain Volatility and Sourcing, Cultural Preference for Fresh Diet)
Market Opportunities (Expansion into Pediatric Nutritional Supplements, Integration of Algae-Derived EPA and DHA, Strategic Partnerships with Clinical Retailers)
Market Trends (Plant-Based Omega-3, Hyper-Personalized Supplementation, Advanced Toxin Remediation, Sustainable Sourcing Compliance)
Government Regulations
SWOT Analysis
Porter's Five Forces Analysis
PESTLE Analysis

UAE EPA and DHA Market Competitive Analysis 19 Sections ▼

Market Share of Major Players
Domestic versus International Import Competition
Algal versus Marine Source Rivalry
Premium Clinical versus Mass-Market Competition
E-commerce versus Pharmacy Channel Dominance
Private Label versus Established Global Brands
Cross Comparison Parameters (Marine Stewardship Council Certification Status, Heavy Metal and PCB Remediation Capability, Cold-Chain Logistics Integration Efficiency, Local Formulation and Packaging Capacity, Clinical Trial Data Transparency Index, Supply Chain Traceability Verification)
Competitive Product Benchmarking (EPA to DHA Ratio Precision, Oxidation TOTOX Value Limits, Toxin Filtration Efficiency, Flavor Masking Technology Effectiveness, Bioavailability of Lipid Form, Capsule Shell Composition)
Financial and Operational Parameters
SWOT Analysis of Major Players
Detailed Profiles of Major Companies
BASF SE (Germany) – PronovaPure, Omegaflex
DSM-Firmenich (Switzerland) – life'sOMEGA, Meg-3
GC Rieber VivoMega (Norway) – VivoMega
Solutex (Spain) – Lipinova
Nordic Naturals (USA) – Ultimate Omega, Arctic Cod Liver Oil
Carlson Labs (USA) – The Very Finest Fish Oil
Blackmores (Australia) – Odourless Fish Oil
Life Extension (USA) – Super Omega-3

UAE EPA and DHA Market End-User Analysis 7 Sections ▼

Daily Supplement Intake per Adult
Average Annual Spend per Household
Penetration in Geriatric Health Categories
Infant Formula EPA and DHA Fortification Rates
Frequency of New-to-Category Trial
Purchase Motivations in Pharmacy Channels
Conversion Rate from General Multivitamins

UAE EPA and DHA Market Future Size (2026-2035) 3 Sections ▼

By Market Value (2026-2035)
By Annual Metric Ton Consumption (2026-2035)
By Average Retail Price Per Gram (2026-2035)

Frequently Asked Questions

Q 01 How big is the UAE EPA and DHA Market? +

The current market size is USD 0.1842 billion in 2025, projected to reach USD 0.3556 billion by 2035 (6.8% CAGR from 2025 to 2035). This growth trajectory reflects the rising consumer focus on cardiovascular health and prenatal nutrition across the United Arab Emirates. The market expansion is supported by increased availability of high-purity omega-3 supplements in retail pharmacies across Dubai and Abu Dhabi.

Q 02 What are the primary growth drivers for the UAE EPA and DHA Market? +

Primary growth drivers include the rising prevalence of lifestyle-related chronic conditions such as hyperlipidemia and cardiovascular disease, which drive healthcare practitioners to recommend omega-3 supplementation. Furthermore, the UAE government's National Strategy for Wellbeing 2031 initiative has significantly encouraged citizens to adopt preventative nutritional measures. Increased disposable income and the proliferation of premium e-commerce platforms specializing in health and wellness further accelerate product adoption.

Q 03 Which major companies lead the UAE EPA and DHA Market? +

Key market participants include Pharmatrade, headquartered in Dubai since 1977, and New Country Healthcare, which has been operational in the region since 1997. Global entities like BASF SE, founded in 1865 in Ludwigshafen, Germany, also maintain a strong supply chain presence for bulk omega-3 concentrates. These firms maintain strategic partnerships with local health authorities to ensure compliance with strict purity standards.

Q 04 What are the significant regulatory challenges for the UAE EPA and DHA Market? +

Market entrants must adhere to the stringent import regulations set by the UAE Ministry of Health and Prevention, specifically regarding the heavy metal testing of marine-derived oils. Compliance with the Emirates Authority for Standardization and Metrology (ESMA) standards is mandatory for all labeling and packaging of EPA and DHA supplements. Navigating these bureaucratic processes often requires extensive clinical documentation and laboratory verification to satisfy federal health requirements.

Q 05 What are the emerging trends in the UAE EPA and DHA Market? +

A notable trend is the shift toward vegan-certified algal oil sources, catering to the growing plant-based consumer demographic in Sharjah and Ras Al Khaimah. Manufacturers are increasingly integrating blockchain technology into their supply chains to provide consumers with transparent information regarding the sustainability of fish stocks. Additionally, liquid-form omega-3 variants, which offer higher bioavailability for pediatric patients, are gaining significant traction in clinical pediatric practices.